HomeRGC • NASDAQ
add
Regencell Bioscience Holdings Ltd
Previous close
$14.86
Day range
$14.15 - $15.60
Year range
$0.080 - $83.60
Market cap
7.17B USD
Avg Volume
2.24M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 988.92K | -14.45% |
Net income | -926.81K | 10.31% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -912.47K | 15.72% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | 7.48M | -28.60% |
Total liabilities | 763.84K | 144.39% |
Total equity | 6.72M | — |
Shares outstanding | 494.49M | — |
Price to book | 1.49K | — |
Return on assets | -33.06% | — |
Return on capital | -36.82% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -926.81K | 10.31% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2014
Website
Employees
12
